Please login to the form below

human growth hormone

This page shows the latest human growth hormone news and features for those working in and with pharma, biotech and healthcare.

FDA takes aim at pharma’s biosimilar-delaying tactics

Insulin action. Gottlieb is also planning to take action on high prices for insulin and other drugs such as human growth hormone which have seen their prices escalate in recent years.

Latest news

CHMP recommends Teva's generic version of Astellas' Advagraf

The committee also recommended that Faslodex could be used in combination with Pfizer’s breast cancer drug Ibrance (palbociclib) to treat hormone receptor positive, human epidermal growth factor receptor 2-negative ... The combination can also be used
Lilly gets early US approval for Ibrance rival abemaciclib

The US FDA has approved the CDK 4/6 inhibitor - which will be sold as Verzenio - as a combination treatment with hormone drug fulvestrant for hormone receptor-positive, human epidermal growth
Versartis crashes as VELOCITY trial veers off track

The US biotech's somavaratan proved inferior to Pfzier’s Genotropin. US biotech Versartis saw more than 80% wiped off its share price ahead of the weekend after its growth hormone ... The long-acting human growth hormone (hGH) product had been billed
Surging Trulicity takes sting out of Lilly's arthritis setback

New chief executive David Ricks needs the drug and other growth brands to fire on all cylinders to help Lilly ride through the recent disappointment of a surprise FDA rejection for ... receptor-positive (HR+), human epidermal growth factor receptor
Pfizer keeps nose ahead of rivals with new Ibrance approval

The US FDA has converted its earlier conditional approval of Ibrance (palbociclib) into full approval as a first-line treatment of post-menopausal women with hormone receptor positive, human epidermal growth

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest Intelligence

Implementing eHealth innovation

Medications management and eHealth. The reference treatment for patients with GHD is based on recombinant human growth hormone (rhGH) which is identical to the growth hormone produced by the pituitary gland. ... growth hormone deficiency, one in which
Pharma deals during December 2014

costs. Pfizer has also signed up to a drug delivery product this month through its $570m licensing deal with Opko Health for a long acting version of human growth hormone (hGH), ... which is currently in phase III trials for the treatment of growth

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Pharma and free medicines: a different perspective

Palbociclib is approved for the treatment of patients with locally advanced or metastatic breast cancer, specifically those who have hormone receptor-positive and human epidermal growth factor receptor 2-negative disease. ... The committee found that

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director, Medical Education: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director: Competitive Salary Offered

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Global Business Development Director – Health Education: excellent commission

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Senior Account Manager: Competitive Salary Offered

Account Director, Healthcare Marketing Agency: Salary TBC

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Account Director – Healthcare Marketing – Berks: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Senior Medical Writer: Salary TBC

Business Director: Competitive Salary Offered

Account Manager / Account Director: Competative

Account Director – Health Policy – Global Agency: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Associate Director: £75, 000-90, 000

Senior Account Director development role to Business Director, H...: Excellent package

Medical Writer: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Director – Healthcare PR – Global Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch: ...